KRAS:

Fernand Bteich1,2, Mahshid Mohammadi2,3, Terence Li2,3

  • 1Department of Medical Oncology, Montefiore Medical Center, Bronx, NY 10467, USA.

概括

针对结肠直肠癌 (CRC) 中的KRAS突变,新的抑制剂正在推进. 组合疗法对于克服KRAS突变CRC治疗中的耐药性至关重要.